ESMO Preceptorship Advanced NRHC Pancreatic France 2019 Banner

Start date: 06 Dec 2019
End date: 07 Dec 2019
Location: Paris, France

Learning objectives

To understand epidemiology, aetiology and molecular biology of hepatocellular carcinoma (HCC), biliary and pancreatic cancers
To understand multidisciplinary management and treatment of advanced non resectable hepatocellular carcinoma, biliary and pancreatic cancers
To learn about advances in the treatment and novel targets in hepatobiliary (HPB) carcinomas
To address complex cases management frequently encountered in daily practice, related with these diseases

Accreditation

The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Konstantinos Kamposioras, United Kingdom
Julien Taieb, France